The article discusses a study on tamoxifen adherence and its relationship to mortality in male breast cancer patients. It references a study by S. Xu et al., published in a 2012 issue of the "Breat Cancer Research and Treatment". It shows that low social support, lower age and the occurrence of adverse effects were associated with lower levels of tamoxifen adherence.